This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, Rational Drug Design Laboratories. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 6 Years Active: 1998
Title: Nobuyuki Katoh: Innovator in Hepatitis C Research
Introduction
Nobuyuki Katoh is a prominent inventor based in Tokyo, Japan. He is recognized for his significant contributions to the field of hepatitis C research. His work has led to advancements in the detection and treatment of this viral infection.
Latest Patents
Nobuyuki Katoh holds a patent for a nucleic acid of C type hepatitis virus derivation and process for detection. The objective of this invention is to clarify the sequence of the 3'-end site of the HCV genome and to provide a new process for detecting HCV. A new sequence with a highly conserved 3'-end site of the HCV genome has been identified. Using these sequences, new processes for detecting HCV and inhibiting its proliferation have been developed. He has 1 patent to his name.
Career Highlights
Throughout his career, Nobuyuki Katoh has worked with notable organizations such as Rational Drug Design Laboratories and the National Cancer Center. His experience in these institutions has allowed him to contribute significantly to medical research and innovation.
Collaborations
Nobuyuki Katoh has collaborated with esteemed colleagues, including Torahiko Tanaka and Kunitada Shimotohno. These partnerships have further enhanced his research and development efforts in the field of hepatitis C.
Conclusion
Nobuyuki Katoh's innovative work in hepatitis C research has made a lasting impact on the medical community. His contributions continue to pave the way for advancements in the detection and treatment of this virus.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile